Bank of New York Mellon’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
2017
Q4
$542K Buy
2017
Q3
$598K Sell
2017
Q2
$574K Buy
2017
Q1
$85K Sell
2016
Q4
$122K Buy
2016
Q3
$176K Sell
2016
Q2
$116K Sell
2016
Q1
$417K Buy
2015
Q4
$722K Sell
2015
Q3
$917K Sell
2015
Q2
$1.53M Buy
2015
Q1
$544K Buy
2014
Q4
$598K Buy
2014
Q3
$594K Buy
2014
Q2
$970K Buy
2014
Q1
$292K Buy
2013
Q4
$142K Hold
2013
Q3
$166K Hold
2013
Q2
$127K Buy